Articles with keyword inhibitor

Systemic treatment of hepatocellular carcinoma: practical issues and perspectives (V.V. Breder, K.K. Laktionov)

hepatocellular carcinoma, multi-kinase inhibitors, checkpoint inhibitors.

2018 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE (F.V. Moiseenko, V.M. Moiseyenko)

cancer, treatment, immunotherapy, checkpoint inhibitors.

MOLECULAR TARGETS IN LUNG CANCER: CURRENT STATUS (E.N. Imyanitov)

lung cancer, mutation, smoking, tumor, inhibitor

FUTURE OF SYSTEMIC THERAPY IN ONCOUROLOGY: TARGETED AND IMMUNOTHERAPY (F.V. Moiseenko)

immunotherapy, targeted therapy, checkpoint inhibitors, urothelial cancer, renal cell cancer.

2015 main events in drug therapy (F.V. Moiseenko)

immunotherapy, program cell death protein inhibitors, targeted therapy, cancer drug therapy

20 YEARS OF TARGETING THERAPY OF SOLID TUMORS. SUCCESSES AND FAILURES (A.A. Tryakin, M.Yu. Fedyanin, I.A. Pokataev)

targeted therapy, precision medicine, tyrosine kinase inhibitor, biomarker, oncology; review.

CANCER IMMUNOTHERAPY (N.M. Volkov)

cancer immunotherapy, immune check-point inhibitors, chimeric antigen receptor, clinical trials.

A history of cancer immunotherapy (V.M. Moiseyenko, N.M. Volkov)

anticancer immunity, cancer immunotherapy, history, vaccines, cytokines, adoptive therapy, antibody, immune check-point inhibitor